The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy
Goal Attainment Scaling
DOI:
10.1016/j.jval.2024.12.004
Publication Date:
2024-12-27T16:51:28Z
AUTHORS (14)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....